KATELYN NEUFELD: Open Payments
NPI 1689289357 · PORT ORCHARD, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 12 payments from 7 companies in 2025. Trend: 2023 $210 · 2024 $496 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $79 |
| Lilly USA, LLC | 3 | $59 |
| PFIZER INC. | 2 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $35 |
| Amgen Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: MOUNJARO, NURTEC ODT, JARDIANCE, Ozempic, REPATHA, GARDASIL 9, SHINGRIX.
Industry payments across WA — which companies pay providers there.
